REG - BAE SYSTEMS PLC - Transaction in Own Shares

RNS Number : 1914M BAE SYSTEMS PLC 19 December 2025 BAE Systems plcTransaction in own sharesBAE Systems plc (the "Company") announces that, in accordance with the terms of its share repurchase programme announced on 2 August 2023 (the "Buyback Programme") and following the announcement on 1 July 2025 in relation to the initiation of the second tranche (the "Second Tranche") of the Buyback Programme, it has purchased for cancellation the following number of its ordinary shares of 2.5 pence each on the London Stock Exchange from Morgan Stanley & Co. International plc ("Morgan Stanley"):Date of purchase: 18 December 2025Number of ordinary shares purchased: 98,316Highest price paid per ordinary share (p): 1,711.50Lowest price paid per ordinary share (p): 1,682.00Volume weighted average price paid per share (p): 1,693.04The Company intends to cancel all of the purchased ordinary shares.In accordance with Article 5(1)(b) of the Market Abuse Regulation (EU) No 596/2014 (as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018, as amended), a full breakdown of the individual purchases of ordinary shares made by Morgan Stanley on behalf of the Company can be found at:http://www.rns-pdf.londonstockexchange.com/rns/1914M_1-2025-12-18.pdfIn relation to the Second Tranche, the Company has purchased 14,459,888 ordinary shares in aggregate at a volume weighted average price of 1,812.16p per ordinary share.This announcement does not constitute, or form part of, an offer or any solicitation of an offer for securities in any jurisdiction.This announcement will also be available on the Company's website at: https://investors.baesystems.com/regulatory-news- ENDS -For further information, please contact:Investor RelationsDirector, Media RelationsTelephone: +44 (0) 3300 46 6802Telephone: +44 (0) 7540 628673Email: investors@baesystems.comEmail: kristina.anderson@baesystems.comThis information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy. END POSTPBRTMTBBBFA